Walgreens shares fell more than 5% Friday as details about a potential sale emerged and one analyst team said the stock had ...

Deutsche Bank analyst George Hill downgraded Walgreens stock to Sell from Hold and reduced his price target to $9 from $11 in ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

The deal is not yet finalized. Other news includes: tariffs on the pharmaceutical industry and what it means for medicine; Pfizer putting emphasis on merit in the face of DEI overhaul; and more.

Explore the uncertain future of Walgreens Boots Alliance (WBA) amid buyout hurdles, litigation risks & industry challenges.

Deutsche Bank believes the hype over a Sycamore buyout and subsequent breakup has gone too far, and puts the deal at risk.

But not enough patients visited VillageMD’s doctors, and the business is now up for sale. Brewer exited in September 2023 and Walgreens last year took a $5.8bn after-tax charge related to VillageMD, ...

Deutsche Bank downgraded Walgreens Boots Alliance (WBA) to Sell from Hold with a price target of $9, down from $11. The firm says the reports ...

Boots’ prospective buyer Sycamore Partners is planning to separate the UK retail pharmacy business from its US and healthcare ...